Elevation Oncology GAAP EPS of -$0.41 beats by $0.18
- Elevation Oncology press release (NASDAQ:ELEV): Q4 GAAP EPS of -$0.41 beats by $0.18.
- As of December 31, 2021, the Company had cash and cash equivalents totaling $146.3M
Recommended For You
Comments
Have a tip? Submit confidentially to our News team. Found a factual error? Report here.